Monopar Therapeutics (MNPR) News Today: Latest Market and Industry Updates

72.985
1.0350
1.44 %
Daily range
Weekly range
  • Yaroslav Dmytrenko
  • Yesterday
Monopar Therapeutics stock forecast: Downside risk remains high with sellers in control
Monopar Therapeutics (MNPR) stock is trading at $72.38, down 6.06% on the day. The price currently sits below its key moving averages, reflecting continued pressure from ...
  • Aleksandra Chaikina
  • 09.10.2026
Monopar Therapeutics shares technical analysis: Pullback dominates after recent selling
Monopar Therapeutics (MNPR) stock is trading at $80.3 after a decline of 4.38% today. The price sits below its key short-term average, but remains above primary medium- ...
  • Aleksandra Chaikina
  • 07.10.2026
Why is Monopar Therapeutics stock rising today? Short-term buyer dominance confirmed, resistance levels in focus
Monopar Therapeutics (MNPR) stock is trading at $83.64, rising 4.77% on the day and closing near the session’s high. The price remains above its key moving averages, ...
  • Viktoras Karapetjanc
  • 06.10.2026
MNPR rises as buyers remain active during intraday volatility
Monopar Therapeutics (MNPR) stock is trading at $82.09, up 4.64% for the day. The price is currently positioned above its key short- and long-term moving ...
  • Ezequiel Gomes
  • 29.09.2026
Form 4 insider transaction filed pressures Monopar Therapeutics stock below $74.23 support
Monopar Therapeutics Inc. (MNPR) stock is trading at $80, down 4.54% on the day. The price sits below its key moving averages for the short and medium term, indicating ...
  • Dmytro Kharkov
  • 25.09.2026
Monopar Therapeutics stock price prediction: Support pressure looms at $81.33
Monopar Therapeutics (MNPR) stock is trading at $86.35, down 3% on the day. The price sits below its short- and medium-term moving averages but continues to hold above ...
  • Ivan Andriyenko
  • 23.09.2026
Monopar Therapeutics shares drop more than 7% after stock trades below short-term moving averages
Monopar Therapeutics Inc. (MNPR) slumped 7.26% as continued weak momentum and firm selling pressure drove the latest move lower. The decline is supported by the stock trading beneath its 20-day ...
  • Ezequiel Gomes
  • 23.09.2026
Why is Monopar Therapeutics stock down today? Key support levels to watch
Monopar Therapeutics (MNPR) stock is trading at $90.91 after a daily decline of 5.91%. The move places the stock below its key short- and medium-term moving averages but ...
  • Dmytro Kharkov
  • 18.09.2026
MNPR slides nearly 5% as technical indicators confirm continued short-term weakness
Monopar Therapeutics Inc. (MNPR) declined 4.93% today as sustained selling pressure and negative momentum continued to dominate short-term trading. The move is supported by the stock's weakness ...
  • Anastasiia Chabaniuk
  • 18.09.2026
Monopar Therapeutics stock trades near $92.46 support amid ongoing pullback
Monopar Therapeutics (MNPR) stock is trading at $97.14, registering a sharp daily decline of 5.27%. The price currently sits below its short- and medium-term moving ...
  • Mykhailo Ihnatenko
  • 15.09.2026
Monopar Therapeutics stock forecast: Selloff remains in focus
Monopar Therapeutics (MNPR) stock is trading at $104.47, marking a daily drop of 3.38%. The price sits below its short- and medium-term moving averages but remains ...
  • Ezequiel Gomes
  • 01.09.2026
Monopar Therapeutics shares technical analysis: $120.21 resistance in focus after rally
Monopar Therapeutics (MNPR) stock is trading at $115.47, up 3.16% on the day and holding above its key moving averages. The price remains well supported relative to ...
  • Ezequiel Gomes
  • 31.08.2026
What's behind Monopar Therapeutics's latest 3.0% stock pullback?
Monopar Therapeutics Inc. (MNPR) fell 3.04% amid renewed technical selling pressure, with price action reflecting clear intraday weakness. The latest move is limited by mixed momentum signals and ...
  • Ezequiel Gomes
  • 28.08.2026
Will Monopar Therapeutics stock regain momentum as oversold conditions limit further selling?
Monopar Therapeutics (MNPR) stock is trading at $110.25, marking a daily decline of 3.15%. The price is positioned below its key short- and medium-term moving averages, ...
  • Jainam Mehta
  • 26.08.2026
Monopar Therapeutics stock resistance test: Key levels to watch
Monopar Therapeutics (MNPR) stock is trading at $114.33, up 3.17% on the day and closing near the session’s high. The move lifts the stock above its key moving ...
  • Emilio Ghigini
  • 20.08.2026
MNPR drops as short-term selling pressure persists
Monopar Therapeutics (MNPR) stock is trading at $117.65, down 5.31% on the session. The price is currently below its key short-term moving average, but remains above ...
  • Oleg Tkachenko
  • 20.08.2026
What's behind Monopar Therapeutics's latest stock pullback?
Monopar Therapeutics Inc. (MNPR) dropped 4.8% today as technical overbought conditions triggered heavy intraday selling pressure. The pullback is supported by the stock's proximity to major ...
  • Jainam Mehta
  • 06.08.2026
Why is Monopar Therapeutics stock up today? Resistance levels in focus
Monopar Therapeutics (MNPR) stock is trading at $123.63, up 3.59% on the day and sitting above its key moving averages. The stock continues to show strong momentum ...
  • Andreas Kristo
  • 04.08.2026
Monopar Therapeutics stock approaches $125.77 resistance as bullish momentum drives gains
Monopar Therapeutics (MNPR) stock is trading at $119.35 today, surging 6.91% for the session. The price sits well above its key moving averages, reflecting strong upward ...
  • Ashutosh Sureka
  • 03.08.2026
Monopar Therapeutics stock closes near session high as buyers regain control
Monopar Therapeutics (MNPR) stock is trading at $111.85 after a 3.35% daily gain, ending close to the session high. The price is currently below its short-term averages ...
  • Ciaran Ryan
  • 31.07.2026
Why is Monopar Therapeutics stock down today? Key support levels to watch
Monopar Therapeutics (MNPR) stock is trading at $111.26 after declining 2.93% on the day. The stock remains above its key moving averages, showing resilience relative to ...